肌缩性侧面硬化症的遗传结构:一个全面的审查
Lamei Yuan1, Yuewen Yang2, Yi Guo3
1Research Center of Medical Experimental Technology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China; Center for Experimental Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China; Disease Genome Research Center, Central South University, Changsha, Hunan 410013, China; Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Journal of genetics and genomics = Yi chuan xue bao
|May 30, 2025
概括
肌缩侧面硬化症 (ALS) 涉及运动神经元退化. 遗传因素至关重要,鉴定了32个基因和34个位点,为个性化治疗提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种流行的神经退行性疾病,导致运动神经元逐渐退化.
- 它会导致肌肉衰弱,,并在2-4年内死亡.
- ALS被分为家族性 (FALS,约10%的病例) 或零星性,具有不同的遗传模式.
研究的目的:
- 审查ALS的临床和神经病理特征.
- 要总结已识别的致病基因,基因和遗传易感性因素.
- 讨论致病机制和最近在ALS遗传学和途径方面的进展.
主要方法:
- 文献综述侧重于ALS临床特征,病理学,遗传学和动物模型.
- 对已识别的致病基因和基因进行分析.
- 检查致病途径和神经退行机制.
主要成果:
- 已经确定了34多个引起疾病的位点和32个ALS基因.
- 遗传因素在ALS病变发生过程中起着关键作用.
- 突变蛋白和动物模型为神经退行提供了洞察力.
结论:
- 了解ALS的遗传基础对于揭开病原机制至关重要.
- 遗传发现为开发针对ALS的个性化治疗铺平了道路.
- 对遗传因素和途径的进一步研究可以导致有效的治疗策略.
相关概念视频
03:03Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
01:15Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723